Excalibur Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Sell |
1,418
-50
| -3% | -$39K | 0.41% | 68 |
|
|
2025
Q1 | $1.21M | Buy |
1,468
+2
| +0.1% | +$1.65K | 0.48% | 61 |
|
|
2024
Q4 | $1.13M | Buy |
1,466
+88
| +6% | +$67.9K | 0.45% | 64 |
|
|
2024
Q3 | $1.22M | Buy |
1,378
+6
| +0.4% | +$5.32K | 0.47% | 62 |
|
|
2024
Q2 | $1.24M | Buy |
1,372
+83
| +6% | +$75.1K | 0.51% | 53 |
|
|
2024
Q1 | $1M | Hold |
1,289
| – | – | 0.42% | 64 |
|
|
2023
Q4 | $751K | Hold |
1,289
| – | – | 0.35% | 74 |
|
|
2023
Q3 | $692K | Buy |
1,289
+18
| +1% | +$9.67K | 0.36% | 73 |
|
|
2023
Q2 | $596K | Buy |
1,271
+9
| +0.7% | +$4.22K | 0.3% | 81 |
|
|
2023
Q1 | $433K | Hold |
1,262
| – | – | 0.22% | 98 |
|
|
2022
Q4 | $462K | Hold |
1,262
| – | – | 0.24% | 95 |
|
|
2022
Q3 | $408K | Hold |
1,262
| – | – | 0.23% | 92 |
|
|
2022
Q2 | $409K | Buy |
1,262
+1
| +0.1% | +$324 | 0.21% | 102 |
|
|
2022
Q1 | $361K | Hold |
1,261
| – | – | 0.16% | 115 |
|
|
2021
Q4 | $348K | Hold |
1,261
| – | – | 0.14% | 121 |
|
|
2021
Q3 | $291K | Hold |
1,261
| – | – | 0.13% | 133 |
|
|
2021
Q2 | $289K | Buy |
1,261
+11
| +0.9% | +$2.52K | 0.13% | 133 |
|
|
2021
Q1 | $234K | Hold |
1,250
| – | – | 0.12% | 139 |
|
|
2020
Q4 | $211K | Buy |
+1,250
| New | +$211K | 0.11% | 139 |
|
|
2020
Q3 | – | Sell |
-1,250
| Closed | -$205K | – | 144 |
|
|
2020
Q2 | $205K | Buy |
+1,250
| New | +$205K | 0.14% | 110 |
|